These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 31682762)
1. Serotype evolution in Western Europe: perspectives on invasive pneumococcal diseases (IPD). Tin Tin Htar M; Morato Martínez J; Theilacker C; Schmitt HJ; Swerdlow D Expert Rev Vaccines; 2019 Nov; 18(11):1145-1155. PubMed ID: 31682762 [No Abstract] [Full Text] [Related]
2. Pneumococcal serotype evolution in Western Europe. Tin Tin Htar M; Christopoulou D; Schmitt HJ BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008 [TBL] [Abstract][Full Text] [Related]
3. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec. De Wals P; Lefebvre B; Deceuninck G; Longtin J Vaccine; 2018 Jan; 36(3):421-426. PubMed ID: 29224962 [TBL] [Abstract][Full Text] [Related]
4. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children. Kendall BA; Dascomb KK; Mehta RR; Stockmann C; Mason EO; Ampofo K; Pavia AT; Byington CL Vaccine; 2016 Jan; 34(4):474-478. PubMed ID: 26706276 [TBL] [Abstract][Full Text] [Related]
5. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014. Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682 [TBL] [Abstract][Full Text] [Related]
6. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014. Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268 [TBL] [Abstract][Full Text] [Related]
7. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related]
8. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis. Balsells E; Guillot L; Nair H; Kyaw MH PLoS One; 2017; 12(5):e0177113. PubMed ID: 28486544 [TBL] [Abstract][Full Text] [Related]
9. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany. van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078 [TBL] [Abstract][Full Text] [Related]
10. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil. Brandileone MC; Almeida SCG; Minamisava R; Andrade AL Vaccine; 2018 May; 36(19):2559-2566. PubMed ID: 29650385 [TBL] [Abstract][Full Text] [Related]
11. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
12. Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska. Bruce MG; Singleton R; Bulkow L; Rudolph K; Zulz T; Gounder P; Hurlburt D; Bruden D; Hennessy T Vaccine; 2015 Sep; 33(38):4813-9. PubMed ID: 26247901 [TBL] [Abstract][Full Text] [Related]
13. The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage. Ciruela P; Izquierdo C; Broner S; Muñoz-Almagro C; Hernández S; Ardanuy C; Pallarés R; Domínguez A; Jané M; Vaccine; 2018 Nov; 36(50):7744-7752. PubMed ID: 30473132 [TBL] [Abstract][Full Text] [Related]
14. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13. Redin A; Ciruela P; de Sevilla MF; Gomez-Bertomeu F; Gonzalez-Peris S; Benitez MA; Trujillo G; Diaz A; Jou E; Izquierdo C; Perez-Moreno MO; Moraga-Llop F; Olsina M; Vinado B; Sanfeliu E; Garcia A; Gonzalez-di Lauro S; Garcia-Garcia JJ; Dominguez A; Sa-Leao R; Muñoz-Almagro C; Microbiol Spectr; 2021 Dec; 9(3):e0115021. PubMed ID: 34878302 [TBL] [Abstract][Full Text] [Related]
15. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lo SW; Gladstone RA; van Tonder AJ; Lees JA; du Plessis M; Benisty R; Givon-Lavi N; Hawkins PA; Cornick JE; Kwambana-Adams B; Law PY; Ho PL; Antonio M; Everett DB; Dagan R; von Gottberg A; Klugman KP; McGee L; Breiman RF; Bentley SD; Lancet Infect Dis; 2019 Jul; 19(7):759-769. PubMed ID: 31196809 [TBL] [Abstract][Full Text] [Related]
16. The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage. Tin Tin Htar M; Sings HL; Syrochkina M; Taysi B; Hilton B; Schmitt HJ; Gessner BD; Jodar L Expert Rev Vaccines; 2019 Dec; 18(12):1243-1270. PubMed ID: 31587592 [No Abstract] [Full Text] [Related]
17. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012. Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Lovgren M; Tyrrell GJ; Desai S; Sherrard L; Adam H; Gilmour M; Zhanel GG; ; Can J Microbiol; 2013 Dec; 59(12):778-88. PubMed ID: 24313450 [TBL] [Abstract][Full Text] [Related]
18. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure. Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A; Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556 [TBL] [Abstract][Full Text] [Related]
19. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Isaacman DJ; McIntosh ED; Reinert RR Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359 [TBL] [Abstract][Full Text] [Related]
20. Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination. Grant LR; Slack MPE; Theilacker C; Vojicic J; Dion S; Reinert RR; Jodar L; Gessner BD Clin Infect Dis; 2023 Feb; 76(3):e1062-e1070. PubMed ID: 35789262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]